The 18th International Symposium on Mucopolysaccharidoses and Related Lysosomal Diseases will take place on June 4-7, 2026, in Florence, Italy at Palazzo Affari and Palazzo dei Congressi. This global event will reflect on the last 20 years of progress made in Mucopolysaccharidoses (MPSs) and set sights on the next 20 years of innovation, advocacy, and collaboration. […]
18th International MPS 2026 Symposium & MPS MasterClass Read More »
MetabERN recently hosted its annual three-day board meeting in Budapest. This successful event brought together approximately 100 participants.
MetabERN Board Meeting 2024: updates from Budapest Read More »
E-Rare’s 2018 funding call supports international research teams using multi-omic approaches to investigate rare disease mechanisms.
The Innovative Medicines Initiative’s Call 13 offered funding opportunities across multiple medical research domains through February 2018.
MetabERN contributed to discussions on personalizing healthcare through rare disease expertise at the 20th European Health Forum Gastein.
An international observational study recruiting PMM2-CDG patients launches across multiple centers in Europe and the United States.
Prospective multicenter natural history study in PMM2-CDG Read More »
Professor Derks launches an initiative gathering community input to establish research priorities for liver Glycogen Storage Disease.
Message from Prof Terry Derks, Metabolic Diseases Groningen Read More »
The Italian Ministry of Health’s ERN Info Day showcased Italy’s leading role in European rare disease networks and patient care advancement.
The European Union approves groundbreaking unified registry for inherited metabolic disorders, advancing research and patient care.
A Unified Registry for Inherited Metabolic Disorders (U-IMD) Read More »
Professor Maurizio Scarpa appointed as first Chairman of the European Reference Networks Board of Coordinators in historic decision.
Hey, want to upgrade to pro plan?
Upgrade Now
& get 25% off
Offer valid only for 24 hrs.
